Clinical Relevance of Brain Atrophy Measures in Multiple Sclerosis
Magnetic resonance imaging of the brain and spinal cord in patients with multiple sclerosis is crucial for diagnosis as well as monitoring and predicting disease activity. Comprehensive MR measurements including assessment of brain and spinal cord volume changes have the potential to improve patient...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Prague
Karolinum Press
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_121168 | ||
| 005 | 20231031 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231031s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9788024651965 | ||
| 020 | |a 9788024651965 | ||
| 020 | |a 9788024656922 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.14712/9788024651965 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Uher, Tomáš |4 auth | |
| 245 | 1 | 0 | |a Clinical Relevance of Brain Atrophy Measures in Multiple Sclerosis |
| 260 | |a Prague |b Karolinum Press |c 2023 | ||
| 300 | |a 1 electronic resource (83 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Magnetic resonance imaging of the brain and spinal cord in patients with multiple sclerosis is crucial for diagnosis as well as monitoring and predicting disease activity. Comprehensive MR measurements including assessment of brain and spinal cord volume changes have the potential to improve patient monitoring, allow earlier detection of subclinical disease activity, and identify patients with depleted brain reserve who are at highest risk of disability progression. Cerebral atrophy measurements are now a secondary outcome of many clinical trials, although their wider use in routine clinical practice is still hampered by some technical limitations. However, evidence from clinical practice shows that assessment of brain and spinal cord volume change is feasible and has the potential to improve patient treatment. | ||
| 536 | |a European Commission | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a multiple sclerosis | ||
| 653 | |a brain atrophy | ||
| 653 | |a diagnosis | ||
| 653 | |a measurements | ||
| 653 | |a disease | ||
| 653 | |a monitoring | ||
| 653 | |a magnetic resonance | ||
| 653 | |a cerebral atrophy | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://dspace.cuni.cz/bitstream/handle/20.500.11956/186866/9788024651965.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/121168 |7 0 |z DOAB: description of the publication |